Environment And Sanitation Tenders

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Substance Golimumab, Atc L04ab06 for the Period 07/01/2023 - 06/30/2025

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Substance Lapatinib, Atc L01eh01 for the Period 07/01/2023 - 06/30/2025

Be-Brussels: Call for Expressions of Interest

Dynamic Purchasing System for Alternative Education Provision

London and Quadrant Housing Trust - Supply/Distribution of Ironmongery Dynamic Purchasing System (Dps)

Centralized Public Procurement of Structural Expertise and Expert Approval Services Using a Dynamic Procurement System

Chemical Screening and Optimization Facility (X01 Clinical Trial not Allowed)

Conclusion of Non-Exclusive Drug Discount Agreements According to § 130A Para. 8 Sgb V by Means of a So-Called Open House Model for the Active Substance Fusidic Acid/Betamethasone (Atc Code According to Who: D07cc01)

Conclusion of Non-Exclusive Discount Agreements in Accordance with §§ 130A Para. 8/130C Para. 1 Sgb V for Drugs with the Active Ingredient Somatropin (H01ac01) as Part of a So-Called Open House Model.

Drugs with the Active Ingredient Combination Olodaterol and Tiotropium Bromide (Atc: R03al06)